Sort
8,912 grants matching “sars cov 2”
Administrative Core
$303,844Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2023 · AI
Next generation implicit solvation for atomistic modeling
$303,804Alexey Vlad Onufriev · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · GM
EAGER: Rapid Planar PCR for COVID-19 Testing
$303,685Gregory W Faris · Numentus Technologies Inc. · · FY2021 · ENG
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
$303,268Christopher L King · Case Western Reserve University · U01 · FY2024 · CA
Sensitive and Quantitative MS-bases Glycomic Mapping Platform
$302,855Yehia Mechref · Texas Tech University · R01 · FY2024 · GM
Sensitive and Quantitative MS-bases Glycomic Mapping Platform
$302,855Yehia Mechref · Texas Tech University · R01 · FY2023 · GM
Sensitive and Quantitative MS-bases Glycomic Mapping Platform
$302,855Yehia Mechref · Texas Tech University · R01 · FY2022 · GM
Next generation implicit solvation for atomistic modeling
$302,817Alexey Vlad Onufriev · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · GM
SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use
$302,796Jacek Skarbinski · Kaiser Foundation Research Institute · U01 · FY2024 · CA
Biology of ACE2 activity in the airway epithelium
$302,719Paul B McCray · University Of Iowa · P01 · FY2011 · AI
Core E Data Management Core
$302,630Harm Van Bakel · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Training in HIV Genomics, Treatment, and Cure Research in Botswana
$302,400Joseph Moeketsi Makhema · Botswana-Harvard Aids Institute · D43 · FY2025 · TW
13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
$302,381Amber Reeves-Daniel · Wake Forest University Health Sciences · U01 · FY2025 · DK
Development of a vaccine against SARS-CoV
$302,290Case Western Reserve University · R21 · FY2004 · AI
Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2
$302,099Andrea L Cox · Johns Hopkins University · U54 · FY2022 · CA
School Inner-City Asthma Intervention Study : Human Epidemiology and Response to SARS-COV-2 (HEROS) Supplement
$301,999Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2020 · AI
Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)
$301,599John Scribner Schieffelin · Tulane University Of Louisiana · D43 · FY2024 · TW
SARS-CoV2 Immunity and Cell Biology
$301,514Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$300,959Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2021 · TW
Genetic adjuvants to elicit neutralizing antibodies against HIV
$300,930Ellen Elizabeth Sparger · Tendel Therapies Inc. · R43 · FY2023 · MH
Research Core 1: Molecular Measures Core (RC1)
$300,628Virginia B. Kraus · Duke University · P30 · FY2025 · AG
Cellular and Molecular Mechanisms of COVID-19 Mediated Kidney Injury
$300,384Jonathan Himmelfarb · University Of Washington · UH3 · FY2020 · TR
Epigenetic and environmental factors of ACE2 and TMPRSS2 co-expression
$300,295Joseph Rodriguez · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
COVID-19 Nsp13 Helicase Analysis: Assessment of Unwinding SARS-CoV-2 Mutagenic RNA Secondary Structures and Pharmacological Modulation in a Preclinical Model
$300,143Robert Brosh · National Institute On Aging · ZIA · FY2025 · AG
Genetic adjuvants to elicit neutralizing antibodies against HIV
$300,083Ellen Elizabeth Sparger · Tendel Therapies Inc. · R43 · FY2024 · MH